Ironwood Pharmaceuticals, Inc. - (IRWD) Social Stream
IRONWOOD PHARMACEUTICALS INC (IRWD) Price Targets From Analysts
Use the tables below to see what analysts covering IRONWOOD PHARMACEUTICALS INC think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-08 | 4 | $15 | $9 | $12.75 | $9.6 | 32.81% |
| 2022-01-10 | 3 | $15 | $9 | $12.333 | $9.6 | 28.47% |
| 2022-02-18 | 3 | $15 | $9 | $12 | $9.6 | 25% |
| 2022-05-02 | 4 | $16 | $9 | $13 | $9.6 | 35.42% |
| 2022-06-07 | 3 | $16 | $9 | $12.666 | $9.6 | 31.94% |
| 2022-08-05 | 3 | $16 | $9 | $12.667 | $9.6 | 31.95% |
| 2022-08-16 | 4 | $16 | $9 | $12.75 | $9.6 | 32.81% |
| 2022-11-04 | 5 | $16 | $9 | $13.2 | $9.6 | 37.5% |
| 2023-01-25 | 5 | $16 | $9 | $13.8 | $9.6 | 43.75% |
| 2023-02-17 | 5 | $16 | $9 | $13.6 | $9.6 | 41.67% |
| 2023-05-05 | 4 | $16 | $9 | $13.25 | $9.6 | 38.02% |
| 2023-08-02 | 4 | $19 | $9 | $14 | $9.6 | 45.83% |
| 2023-08-09 | 3 | $20 | $9 | $14.666 | $9.6 | 52.77% |
| 2023-09-28 | 4 | $20 | $9 | $14.666 | $9.6 | 52.77% |
| 2023-10-17 | 4 | $22 | $9 | $16.5 | $9.6 | 71.88% |
| 2023-11-10 | 5 | $22 | $9 | $17.4 | $9.6 | 81.25% |
The Trend in the Analyst Price Target
IRWD's average price target has moved up $5.07 over the prior 22 months.
Over the past 47 weeks, IRWD's average upside potential has been 34.22%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-02-17 | 5 | 16 | 9 | 13.60 | 11.85 | 14.77% |
| 2023-04-27 | 4 | 16 | 9 | 13.25 | 10.42 | 27.16% |
| 2023-08-09 | 3 | 20 | 9 | 14.25 | 9.61 | 48.28% |
| 2023-10-17 | 4 | 22 | 9 | 16.50 | 9.86 | 67.34% |
| 2023-11-10 | 5 | 22 | 9 | 17.40 | 9.74 | 78.64% |
IRWD Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.4 | 4 | 0 | 1 | 0 | 0 | 5 |
The Trend in the Broker Recommendations
Over the past 14 months, IRWD's average broker recommendation rating improved by 0.8.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for IRWD as an investment opportunity.
- In terms of how IRONWOOD PHARMACEUTICALS INC fares relative to all US stocks, note that its number of analysts covering the stock is greater than 229.76% of that group.
- To contextualize these metrics, consider that out of all US stocks, IRONWOOD PHARMACEUTICALS INC's average analyst price target is greater than 278.71% of them.
- In terms of how IRONWOOD PHARMACEUTICALS INC fares relative to Pharmaceutical Products stocks, note that its upside potential (average analyst target price relative to current price) is greater than 390.94% of that group.
- To contextualize these metrics, consider that out of stocks in the mid market cap category, IRONWOOD PHARMACEUTICALS INC's variance in analysts' estimates is lower than -1056.67% of them.
Stocks similar to IRONWOOD PHARMACEUTICALS INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are AGIO, ESPR, and PBYI.
View All Top Stocks by Price Target
Make investment decisions regarding IRWD using the data that counts. Try POWR Ratings for free.